Host: |
Rabbit |
Applications: |
WB/IF/ELISA |
Reactivity: |
Human/Mouse/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-Pyroglutamylated RF-amide peptide receptor (271-320 aa) is suitable for use in Western Blot, Immunofluorescence and ELISA research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
Concentration: |
1 mg/mL |
Dilution Range: |
WB 1:500-1:2000IF 1:200-1:1000ELISA 1:10000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
QRFPR |
Gene ID: |
84109 |
Uniprot ID: |
QRFPR_HUMAN |
Immunogen Region: |
271-320 aa |
Specificity: |
GPR103 Polyclonal Antibody detects endogenous levels of GPR103 protein. |
Immunogen: |
The antiserum was produced against synthesized peptide derived from the human GPR103 at the amino acid range 271-320 |
Function | Receptor for the orexigenic neuropeptide QRFP. The activity of this receptor is mediated by G proteins that modulate adenylate cyclase activity and intracellular calcium levels. |
Protein Name | Pyroglutamylated Rf-Amide Peptide ReceptorAq27G-Protein Coupled Receptor 103Orexigenic Neuropeptide Qrfp ReceptorSp9155 |
Database Links | Reactome: R-HSA-389397Reactome: R-HSA-416476 |
Cellular Localisation | Cell MembraneMulti-Pass Membrane Protein |
Alternative Antibody Names | Anti-Pyroglutamylated Rf-Amide Peptide Receptor antibodyAnti-Aq27 antibodyAnti-G-Protein Coupled Receptor 103 antibodyAnti-Orexigenic Neuropeptide Qrfp Receptor antibodyAnti-Sp9155 antibodyAnti-QRFPR antibodyAnti-GPR103 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance